Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Levy

Showing results (301-310 of 394) with videos related to

Pageof 40
Sort By:
Journal of Neuroimmunology|March 25, 2025
Satralizumab treatment in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case seriesHesham Abboud, Brian Steingo, Diana Vargas, et al.
Annals of Neurology|March 3, 2023
Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum DisorderSean J Pittock, Michael Barnett, Jeffrey L Bennett, et al.
Scientific Reports|February 7, 2024
Anti-aquaporin-4 immune complex stimulates complement-dependent Th17 cytokine release in neuromyelitis optica spectrum disordersShuhei Nishiyama, Jin Myong Seok, Amy E Wright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2016
Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice GuidelineJudith A Paice, Russell Portenoy, Christina Lacchetti, et al.
The New England Journal of Medicine|May 4, 2019
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum DisorderSean J Pittock, Achim Berthele, Kazuo Fujihara, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 13, 2026
Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD ResultsSean J Pittock, Michael H Barnett, Jeffrey L Bennett, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|June 10, 2021
Optic Neuritis-Independent Retinal Atrophy in Neuromyelitis Optica Spectrum DisorderAngeliki G Filippatou, Eleni S Vasileiou, Yufan He, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2020
Evidence of subclinical quantitative retinal layer abnormalities in AQP4-IgG seropositive NMOSDAngeliki G Filippatou, Eleni S Vasileiou, Yufan He, et al.
Annals of Intensive Care|June 4, 2020
Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill childrenMarion Grimaud, Julie Starck, Michael Levy, et al.
Gastrointestinal Endoscopy|January 21, 2020
Outcomes of early endoscopic intervention for pancreatic necrotic collections: a matched case-control studyNicholas Oblizajek, Naoki Takahashi, Sevda Agayeva, et al.
Pageof 40

Showing results (301-310 of 394) with videos related to

Sort By:
Pageof 40
Journal of Neuroimmunology|March 25, 2025
Satralizumab treatment in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case seriesHesham Abboud, Brian Steingo, Diana Vargas, et al.
Annals of Neurology|March 3, 2023
Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum DisorderSean J Pittock, Michael Barnett, Jeffrey L Bennett, et al.
Scientific Reports|February 7, 2024
Anti-aquaporin-4 immune complex stimulates complement-dependent Th17 cytokine release in neuromyelitis optica spectrum disordersShuhei Nishiyama, Jin Myong Seok, Amy E Wright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2016
Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice GuidelineJudith A Paice, Russell Portenoy, Christina Lacchetti, et al.
The New England Journal of Medicine|May 4, 2019
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum DisorderSean J Pittock, Achim Berthele, Kazuo Fujihara, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 13, 2026
Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD ResultsSean J Pittock, Michael H Barnett, Jeffrey L Bennett, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|June 10, 2021
Optic Neuritis-Independent Retinal Atrophy in Neuromyelitis Optica Spectrum DisorderAngeliki G Filippatou, Eleni S Vasileiou, Yufan He, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2020
Evidence of subclinical quantitative retinal layer abnormalities in AQP4-IgG seropositive NMOSDAngeliki G Filippatou, Eleni S Vasileiou, Yufan He, et al.
Annals of Intensive Care|June 4, 2020
Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill childrenMarion Grimaud, Julie Starck, Michael Levy, et al.
Gastrointestinal Endoscopy|January 21, 2020
Outcomes of early endoscopic intervention for pancreatic necrotic collections: a matched case-control studyNicholas Oblizajek, Naoki Takahashi, Sevda Agayeva, et al.
Pageof 40